Reviewed listing: NYSE:GRDN · Analysis dated Oct 22, 2026
It has not been confirmed whether the basis of this analysis still holds today. Read it as a dated earlier assessment; it does not establish a current buying opportunity.
How does the company make money?
Guardian supplies medications to residents of nursing, assisted living, and other long-term care facilities. This includes ordering, packaging, delivery, and support for safe medication use.
What supports the business?
The number of residents served rose by 8 percent to around 210.000 in the second quarter. Revenue and adjusted operating profit grew despite lower drug prices.
What could improve?
More residents and better operations can make profits grow faster than revenue. Small acquisitions expand the network. But that only helps the stock if the high purchase price has not already priced in too much of it.
How is the stock price assessed?
This assessment refers to the analysis and its quoted price shown here. It is not a live quote or a personal recommendation to buy.
38.98 USD looks expensive in my conservative calculation. A ceiling of 30 USD already assumes sustained annual earnings per share of 1.20 USD and a multiple of 25 times those earnings. That is an assumption, not a promise of earnings.
What is the main risk?
Reimbursement rules and large payers affect prices and payments. The latest profit includes a one-time settlement gain. It should not be treated as profit that recurs every year.
What is the overall assessment?
Guardian Pharmacy is growing the number of residents it serves and improving its margin. However, a settlement gain overstates the increase in earnings. At 38.98 USD, the stock already requires substantial future growth and offers little price cushion under a cautious valuation.
Continue exploring this stock in your account
A free Marqora account gives you the detailed analysis with further evidence and lets you compare and save stocks. Your selected stock is kept when you sign in or register.
Open the full analysis in a free account →
Already have an account? Sign in